HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

12th Edition of International Conference on

Neurology and Neurological Disorders

June 22-24, 2026 | Barcelona, Spain

Tau Protein

Tau Protein

Tau protein is an important protein in the human body that helps maintain the function and structure of neurons. It plays a role in microtubule assembly, stabilization, and transport. Microtubules are essential for cell division, transport of organelles and materials, and neuronal signaling. Specifically, tau proteins bind to tubulin molecules and organize the microtubules into bundles which stabilize thecytoskeleton. Tau proteins come in two forms—3R and 4R. 3R tau is more predominant in humans, while 4R tau is the more prevalent form in other species and in humans with certain neurological conditions. Mutations in the tau gene can cause a variety of conditions, including dementia, Alzheimer’s disease, frontotemporal lobar degeneration, and progressive supranuclear palsy. In healthy people, tau helps regulate the structure and function of neurons, which are responsible for storing and transmitting information throughout the body. In Alzheimer’s disease, however, tau proteins begin to accumulate in the axon of neurons, forming neurofibrillary tangles. These tangles interfere with the normal function of neurons, resulting in memory and cognitive impairment. Another implication of tau proteins is the process of aggregation. When tau proteins become chemically modified, they are prone to clustering and forming fibers called paired helical filaments. These fibers, in turn, form insoluble aggregations called neurofibrillary tangles, which are a hallmark of Alzheimer’s disease and other neurological disorders. Tau proteins and its related diseases are the subject of scientific investigation, as research continues to explore its functions and potential therapies. Tau proteins have been used to target therapies for Alzheimer’s disease, stroke, and other neurological diseases. Understanding the nuances of its role in neuronal health and disease could lead to improved treatment modalities for debilitating neurological conditions.

Committee Members
Speaker at Neurology and Neurological Disorders 2026 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2026 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2026 - W S El Masri

W S El Masri

Keele University, United Kingdom

Submit your abstract Today

Watsapp